State Street’s BioRestorative Therapies BRTX Stock Holding History

State Street’s Portfolio BRTX Stock Details BRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.2K	Hold	32,459	–	–	﹤0.01%	4159
2026 Q1	$8.83K	Hold	32,459	–	–	﹤0.01%	4255
2025 Q4	$38K	Buy	32,459 +12,000	+59%	+$16K	﹤0.01%	4194
2025 Q3	$29.3K	Hold	20,459	–	–	﹤0.01%	4215
2025 Q2	$34.2K	Hold	20,459	–	–	﹤0.01%	4148
2025 Q1	$36.4K	Hold	20,459	–	–	﹤0.01%	4137
2024 Q4	$29.3K	Hold	20,459	–	–	﹤0.01%	4189
2024 Q3	$35.6K	Hold	20,459	–	–	﹤0.01%	4154
2024 Q2	$41.5K	Hold	20,459	–	–	﹤0.01%	4171
2024 Q1	$28.2K	Hold	20,459	–	–	﹤0.01%	4252
2023 Q4	$35K	Hold	20,459	–	–	﹤0.01%	4260
2023 Q3	$36.4K	Hold	20,459	–	–	﹤0.01%	4349
2023 Q2	$90.2K	Hold	20,459	–	–	﹤0.01%	4267
2023 Q1	$69.6K	Buy	+20,459	New	+$62.8K	﹤0.01%	4420

Other funds holding BRTX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return

KFGK

Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street's BRTX Position: Q2 2026 in Review

State Street held its BioRestorative Therapies (BRTX) position steady in Q2 2026 at 32,459 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4159.

State Street first reported a position in BRTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $90.2K in Q2 2023. 21 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

State Street held 32,459 shares of BioRestorative Therapies worth $12.2K as of Q2 2026.
State Street left its BioRestorative Therapies share count unchanged in Q2 2026.
BioRestorative Therapies made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4159 holding.
State Street first reported a position in BioRestorative Therapies in Q1 2023 and has held it in 14 quarters since.
State Street's BioRestorative Therapies position peaked at $90.2K in Q2 2023.
21 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.